What are the recommended medications and treatments for a patient with back pain, considering their medical history and potential allergies or sensitivities?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Medications for Back Pain

NSAIDs are the first-line medication for back pain, providing moderate pain relief with the best evidence for efficacy, and should be prescribed at the lowest effective dose for the shortest necessary duration. 1, 2

Acute Back Pain (<12 weeks)

First-Line Pharmacologic Treatment

  • NSAIDs (ibuprofen, naproxen, celecoxib) provide small to moderate improvements in pain intensity and are the preferred initial medication based on good evidence from randomized controlled trials. 1, 2
  • Assess cardiovascular and gastrointestinal risk factors before prescribing any NSAID, as cardiovascular risk increases with longer use and higher doses. 2, 3
  • Celecoxib may be preferred in patients with gastrointestinal risk factors, as it decreased mean 24-hour systolic blood pressure by 0.3 mmHg compared to increases of 3.7 mmHg with ibuprofen and 1.6 mmHg with naproxen. 4
  • Acetaminophen can be considered as an alternative first-line option due to favorable safety profile, though it shows no significant difference from placebo for pain intensity or function. 2

Second-Line Options for Severe Pain

  • Skeletal muscle relaxants (cyclobenzaprine, methocarbamol) improve short-term pain relief after 2-7 days when severe pain persists despite adequate NSAID dosing. 1, 2
  • Prescribe muscle relaxants for time-limited courses only (≤1-2 weeks), as no evidence supports efficacy beyond 2 weeks. 5
  • All skeletal muscle relaxants cause central nervous system adverse effects, primarily sedation, which is dose-related but independent of efficacy. 1, 5
  • Cyclobenzaprine has the largest body of evidence with pooled data from 20 trials (n=1553) showing superiority to placebo for short-term global improvement. 5

Critical Non-Pharmacologic Measures

  • Advise patients to remain active and avoid bed rest, as activity restriction prolongs recovery and delays return to normal activities. 2, 3
  • Application of superficial heat via heating pads provides short-term symptomatic relief and should be recommended alongside NSAIDs. 2, 3

Medications to Avoid in Acute Back Pain

  • Systemic corticosteroids are not recommended, as they have not been shown more effective than placebo for acute low back pain with or without sciatica. 1, 2
  • Benzodiazepines show similar effectiveness to skeletal muscle relaxants but carry risks for abuse, addiction, and tolerance; avoid unless absolutely necessary. 1, 2
  • Insufficient evidence exists to recommend antidepressants or antiseizure medications for acute low back pain. 2

Chronic Back Pain (≥12 weeks)

First-Line Pharmacologic Treatment

  • NSAIDs remain the initial medication of choice with moderate short-term efficacy for pain relief in chronic low back pain. 1, 5
  • Use at the lowest effective dose for the shortest necessary period, with ongoing reassessment of cardiovascular and gastrointestinal risk factors. 5

Second-Line Options

  • Tricyclic antidepressants (amitriptyline, nortriptyline) provide moderate pain relief for chronic low back pain and should be added when NSAIDs alone are insufficient. 1, 5
  • Duloxetine is associated with small improvements in pain intensity and function compared to placebo (moderate-quality evidence) and is particularly useful if chronic pain is accompanied by depression. 5, 6
  • Selective serotonin reuptake inhibitors (SSRIs) may be considered specifically for patients with diabetic neuropathy but have limited evidence for nonspecific chronic back pain. 1

For Radicular Pain/Sciatica

  • Gabapentin shows small to moderate short-term benefits specifically for radicular pain, with doses titrated up to 1200-3600 mg/day in divided doses. 5
  • Start with 300 mg three times daily and increase to therapeutic doses of 1200-3600 mg/day, as lower doses are subtherapeutic. 5
  • Monitor patients on gabapentin for sedation, dizziness, and peripheral edema, and adjust dosing in patients with renal impairment. 5
  • Pregabalin shows no benefit for chronic nonradicular back pain and may actually worsen function. 5

Opioid Considerations

  • Extended-release oral opioids may be used as part of a multimodal strategy for neuropathic or back pain patients when other treatments have failed. 1
  • Opioids have limited evidence for short-term modest effects on chronic low back pain and are associated with nausea, dizziness, constipation, vomiting, somnolence, and dry mouth. 5
  • Substantial risks include aberrant drug-related behaviors, abuse potential, and addiction, requiring careful weighing of benefits and harms before initiating therapy. 2
  • A time-limited trial of tramadol can be considered if pain remains uncontrolled, avoiding stronger opioids due to substantial abuse risks and limited long-term efficacy. 5

Medications to Avoid in Chronic Back Pain

  • Do not prescribe skeletal muscle relaxants for chronic low back pain, as no evidence supports efficacy beyond 2 weeks. 5
  • Benzodiazepines are ineffective for radiculopathy based on low-quality evidence and should be avoided due to risks of abuse and tolerance. 5
  • Systemic corticosteroids are not recommended for chronic low back pain with or without sciatica. 1, 5

Algorithmic Treatment Approach

For Acute Back Pain:

  1. Start with NSAID (ibuprofen 400-800 mg TID, naproxen 500 mg BID, or celecoxib 200 mg daily) after assessing CV/GI risk. 1, 2
  2. Add superficial heat and advise remaining active. 2, 3
  3. If severe pain persists after 2-4 days, add short-term muscle relaxant (cyclobenzaprine 5-10 mg TID for ≤1-2 weeks). 5, 2
  4. Reassess at 1 month; most patients experience substantial improvement within the first month. 3

For Chronic Back Pain Without Radiculopathy:

  1. Start with NSAID at lowest effective dose. 5
  2. If insufficient response after 2-4 weeks, add tricyclic antidepressant (amitriptyline 10-25 mg at bedtime, titrate to 50-75 mg) or duloxetine 30-60 mg daily. 5, 6
  3. Reassess efficacy and side effects regularly. 5
  4. Consider time-limited tramadol trial if pain remains uncontrolled. 5

For Chronic Back Pain With Radiculopathy:

  1. Start with NSAID to target inflammatory component. 5
  2. Add gabapentin 300 mg TID, titrate to 1200-3600 mg/day for neuropathic component. 5
  3. If insufficient response, add tricyclic antidepressant or duloxetine. 5
  4. For acute exacerbations, consider short-term skeletal muscle relaxant. 5
  5. Failure to respond within 4-6 weeks warrants specialist referral for consideration of epidural steroid injections or surgical evaluation. 5

Critical Pitfalls to Avoid

  • Never prescribe bed rest or activity restriction—this provides no benefit and delays recovery. 2, 3
  • Do not use extended courses of medications without clear evidence of continued benefits and absence of major adverse events. 2
  • Do not prescribe muscle relaxants for chronic low back pain or beyond 2 weeks for acute pain. 5
  • Do not use gabapentin at subtherapeutic doses (300 mg TID is insufficient for radicular pain). 5
  • Monitor for hepatotoxicity when using acetaminophen at maximum doses, especially in elderly patients or those with hepatic impairment. 2
  • Patients on celecoxib and concomitant low-dose aspirin experience 4-fold higher rates of complicated ulcers compared to those not on aspirin. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Acute Low Back Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Acute Lower Back Pain in Younger Females

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Alternative Medications for Sciatica and Chronic Back Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.